Avalue's order transparency to September medical products 挹 Note 4 yuan on this year's EPS
Zhang Jiazhe, general manager of Anqin Technology, said that the company's order transparency has been seen in September, medical product orders continue to boom, this year is expected to grow more than 60%, Netcom and POS have received long-term orders from international manufacturers, driving shipments month by month Going higher, this year's profit will exceed 30%. (Photo by Zhang Xuhong, reporter of Juheng Net) Many people use Lishida Mirin Sauce when they are cooking fish,meat and vegetables. Also,it's usually used for making the sauce of noodles and dipping sauce.We select high quality ingredients,so that it can remove the fishy flavour and enhance the fresh and the appearance of cuisines.
We have passed Quality System Certificate,ISO9001 System and HACCP System Certificate,to make sure the safety and high quality.
Mirin Sauce Mirin Spice,Mirin Soy Sauce,Mirin Sauce For Stir Fry,Japanese Mirin Sauce KAIPING CITY LISHIDA FLAVOURING&FOOD CO.,LTD , https://www.lishidafood.com
Production systems and single board computer products Avalue (3479-TW), today (4) held OTC ago Investor Conference, An Qin, general manager Chang Chia-che said the company has seen orders for transparency September, medical Product orders continue to flourish, this year is expected to grow more than 60%, Netcom and POS have received long-term orders from international manufacturers, driving shipments to climb month by month, this year's profit will exceed 30%, the legal estimate, the company's full year After tax, the net profit will be more than 4 yuan.
Anqin's revenue in May was 156 million yuan, up 48.95% over the same period of last year. The accumulated revenue from January to May was 676 million yuan, up 17.53% from the same period last year. Zhang Jiazhe pointed out that the main source of growth is driven by medical bed terminals and sales terminal systems (KIOSK/POS). Avalue’s medical products accounted for 18% of revenue last year and will grow to 65% this year, including bed terminals, ultrasound. Equipment, hemodialyzer systems and single-version products to European and US system integrators (SI) and brand manufacturers will be the main source of growth this year; in addition, the sales endpoint system is the main application area of ​​the company's revenue, the company estimates this year's revenue Growing more than 30%, in addition to the continued strong orders from US convenience store terminals, there are new orders for mainland convenience store photo booths and smart sports equipment, and the growth momentum is quite strong.
Zhang Jiazhe further pointed out that Anqin has weathered the financial turmoil safely, because more than 70% of the company's products are ODMs, and the risk of self-owned brands is greatly checked. In addition, the marketing strategy is tailored to local conditions. The Americas adopts twin subsidiaries to cultivate and sell; the European part is the committee. The model of cooperation with local distributors will penetrate the products into the countries; as for the Asian region, we are optimistic about China's future market, and neighboring Russia, Vietnam and India's emerging markets. In the second half of the year, we will expand the Chinese sales center into an operation center and actively expand the BRIC. Shikoku.
In addition, Zhang Jiazhe further stated that in order to allow Anqin to have a stronger competitive advantage and battalion of sports, the future will be integrated upstream and downstream, from upstream manufacturing to downstream access, providing one-stop service, reducing costs and increasing gross profit, and can Custom-made products, fully meet the customer's 100% demand, so do not rule out the merger of upstream and downstream manufacturers, and strengthen the company's strength.
Recently, Anqin launched a new generation of medical care system. The product line is complete from low to high. In addition to stabilizing the European and American markets, new customers in mainland China have entered design time this year. The fastest shipment in the first half of this year, the company said. The global medical industry and public construction market continued to grow and demand momentum was strong. Therefore, Anqin launched a series of medical care products, which successively blossomed in the European and American markets. The cumulative shipments exceeded 30,000 units and became the world's No. 1 market share.
Anqin Q1 is not weak in the off-season. It continues the growth momentum of Q4 last year. Orders are influx, and the orders of US lottery machines are doubled. The combined revenue is 553 million yuan, and the net profit after tax is 33.44 million yuan. Benefiting 0.86 yuan, the performance is good. Anqin received orders in April and maintained high-end water level. The revenue was 160 million yuan, up 24.61% over the same period of last year. The accumulated revenue from January to April was 519 million yuan, up 10.5%, showing remarkable performance.
We accept consigned OEM business for well-known brands all over the world.We are looking forward to your contact!